A University of Colorado professor who experienced a funding freeze firsthand this year expressed relief at the program's ...

Kenya is set to roll out the long-acting injectable HIV Pre-Exposure prophylaxis (PrEP) Lenacapavir by January 2026 following ...

These are the words of Rogers Omollo, founder and CEO of Activate Action – a youth-led non-profit organisation that supports ...

The Global Fund has announced that it signed an access agreement with Gilead Sciences to procure lenacapavir, a twice-a-year injection that has a 99 per cent success rate in preventing HIV ...

Popular global HIV/AIDS program PEPFAR has been spared as Congress passes a package with billions of dollars in spending cuts ...

Kenya’s femicide crisis is so pervasive that even female police officers are not immune –– such as victim and mother-of-two ...

Kenya has been selected as one of the 9 early adopter countries for the rollout of Lenacapavir (LEN), a long-acting ...

The third study, Twiga , is an ongoing five-year observational study tracking comorbidities in both HIV-positive and HIV-negative individuals aged 60 and above. It was initiated to better understand ...

In Kenya, American aid workers fired during the Trump administration's purge of USAID ask themselves: What comes next?

Kenya is set to introduce a revolutionary injectable HIV prevention drug, Lenacapavir, becoming one of nine African nations ...

Kenya is among nine African countries, under the low- and middle-income category, that are set to be among the early beneficiaries of lenacapavir, a long-acting HIV prevention drug, following a recent ...

Centre for Epidemiological Modelling and Analysis (CEMA), have released results of three studies that could significantly ...